Purpose In vivo 31P MRSI enables noninvasive mapping of absolute pH values via the pH‐dependent chemical shifts of inorganic phosphates (Pi). A particular challenge is the quantification of extracellular Pi with low SNR in vivo. The purpose of this study was to demonstrate feasibility of assessing both intra‐ and extracellular pH across the whole human brain via volumetric 31P MRSI at 7T. Methods 3D 31P MRSI data sets of the brain were acquired from three healthy volunteers and three glioma patients. Low‐rank denoising was applied to enhance the SNR of 31P MRSI data sets that enables detection of extracellular Pi at high spatial resolutions. A robust two‐compartment quantification model for intra‐ and extracellular Pi signals was implemented. Results In particular low‐rank denoising enabled volumetric mapping of intra‐ and extracellular pH in the human brain with voxel sizes of 5.7 mL. The average intra‐ and extracellular pH measured in white matter of healthy volunteers were 7.00 ± 0.00 and 7.33 ± 0.03, respectively. In tumor tissue of glioma patients, both the average intra‐ and extracellular pH increased to 7.12 ± 0.01 and 7.44 ± 0.01, respectively, compared to normal appearing tissue. Conclusion Mapping of pH values via 31P MRSI at 7T using the proposed two‐compartment quantification model improves reliability of pH values obtained in vivo, and has the potential to provide novel insights into the pH heterogeneity of various tissues.

Highlights MRI derived total 23 Na concentration differs significantly in glioma subregions. Total 23 Na concentration could reflect IDH mutation status and tumor grade. 23 Na MRI yields potential non-invasive biomarkers for the treatment of gliomas.

Purpose Dynamic glucose‐enhanced (DGE)‐MRI based on chemical exchange‐sensitive MRI, that is, glucoCEST and gluco‐chemical exchange‐sensitive spin‐lock (glucoCESL), is intrinsically prone to motion‐induced artifacts because the final DGE contrast relies on the difference of images, which were acquired with a time gap of several mins. In this study, identification of different types of motion‐induced artifacts led to the development of a 3D acquisition protocol for DGE examinations in the human brain at 7 T with improved robustness in the presence of subject motion. Methods DGE‐MRI was realized by the chemical exchange‐sensitive spin‐lock approach based either on relaxation rate in the rotating frame (R1ρ)‐weighted or quantitative R1ρ imaging. A 3D image readout was implemented at 7 T, enabling retrospective volumetric coregistration of the image series and quantification of subject motion. An examination of a healthy volunteer without administration of glucose allowed for the identification of isolated motion‐induced artifacts. Results Even after coregistration, significant motion‐induced artifacts remained in the DGE contrast based on R1ρ‐weighted images. This is due to the spatially varying sensitivity of the coil and was found to be compensated by a quantitative R1ρ approach. The coregistered quantitative approach allowed the observation of a clear increase of the DGE contrast in a patient with glioblastoma, which did not correlate with subject motion. Conclusion The presented 3D acquisition protocol enables DGE‐MRI examinations in the human brain with improved robustness against motion‐induced artifacts. Correction of motion‐induced artifacts is of high importance for DGE‐MRI in clinical studies where an unambiguous assignment of contrast changes due to an actual change in local glucose concentration is a prerequisite.